𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer

✍ Scribed by Mark H. Einstein; Akiva P. Novetsky; Madhur Garg; Susan M. Hailpern; Gloria S. Huang; Arielle Glueck; Abbie L. Fields; Shalom Kalnicki; Gary L. Goldberg

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
144 KB
Volume
109
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly 5-fluorouracil plus cisplatin for
Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer
✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we

Long-term survival in locally advanced o
Long-term survival in locally advanced oral cavity cancer: An analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery
✍ Enzo Maria Ruggeri; Paolo Carlini; Camillo Francesco Pollera; Salvatore De Marco 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Background: Neoadjuvant chemotherapy has been reported to be extremely active in head and neck cancer but has failed to give a statistically significant improvement in survival. ## Methods: From 1981 to 1994, 33 operable patients with locally advanced oral cavity cancer received cisplatin-base

Docetaxel, cisplatin, and 5-fluorouracil
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience
✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime